[Topical tazarotene for severe congenital ichthyosis].
Clinique Dermatologique, Hôtel-Dieu, Nantes. sebastien.barbarot@chu-nante.fr
S
S
Barbarot
A
A
Acher-Chenebaux
J-F
JF
Stalder
D000287:Administration, Topical; D000293:Adolescent; D000328:Adult; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007057:Ichthyosis / Q000188:drug therapy*; D007223:Infant; D007641:Keratolytic Agents / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D009539:Nicotinic Acids / Q000008:administration & dosage*; D011446:Prospective Studies; D012720:Severity of Illness Index; D012176:Retinoids
D007641:Keratolytic Agents; D009539:Nicotinic Acids; C086827:tazarotene; D012176:Retinoids